Information about the 2019 Novel Coronavirus
Clinical Trial to Evaluate the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
Trial ID or NCT#
The HeartAssist 5® VAD System is intended for use as a bridge-to-heart transplantation and will be compared to the HeartMate II and HVAD devices.
Patients that meet the study criteria will be randomized 1:1 to either the HeartAssist 5® VAD System (treatment group) or control group (HeartMate II and HVAD). The physician will have the option to choose which control device to implant.
The primary objective of the study is to show non-inferiority of the HeartAssist 5® (treatment group) to the control group.
Contact us to find out if this trial is right for you.
About this Clinical Trial
Your Message Will Go ToKokil Bakshi
Go Back To The Trial